At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IINN Inspira Technologies Oxy B.H.N. Ltd.
Market Closed 05-03 16:00:00 EDT
2.09
+0.11
+5.56%
盘后2.02
-0.07-3.35%
19:54 EDT
High2.12Low1.95Vol270.37K
Open1.95D1 Closing1.98Amplitude8.50%
Mkt Cap36.14MTradable Cap21.69MTotal Shares17.29M
T/O552.39KT/O Rate2.61%Tradable Shares10.38M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Inspira Technologies Rolls Out Revolutionary Respiratory Device
TIPRANKS  ·  05-02 22:57
Inspira Technologies Rolls Out Revolutionary Respiratory Device
Inspira™ Announces Start of Production of the INSPIRA™ ART100
PR Newswire  ·  05-02 21:18
Inspira™ Announces Start of Production of the INSPIRA™ ART100
Inspira Technologies Achieves CSA Compliance Milestone
TIPRANKS  ·  04-25
Inspira Technologies Achieves CSA Compliance Milestone
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
PR Newswire  ·  04-25
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
Inspira signs collaboration term sheet with the Beilinson Hospital
seekingalpha  ·  04-16
Inspira signs collaboration term sheet with the Beilinson Hospital
BRIEF-Inspira Signs Term Sheet For Use Of Inspira ART100 Device
Reuters  ·  04-16
BRIEF-Inspira Signs Term Sheet For Use Of Inspira ART100 Device
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
PR Newswire  ·  04-16
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
Inspira Announces Breakthrough Infection Prevention Tech
TIPRANKS  ·  04-11
Inspira Announces Breakthrough Infection Prevention Tech
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
PR Newswire  ·  04-10
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
PR Newswire  ·  04-03
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
MSTR, BIOR and ARBK among pre-market losers
seekingalpha  ·  04-01
MSTR, BIOR and ARBK among pre-market losers
Inspira Technologies declines 9% on $1.65M direct funding
seekingalpha  ·  04-01
Inspira Technologies declines 9% on $1.65M direct funding

Introduction

Company Name.
Inspira Technologies Oxy B.H.N. Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.
Issue price:
--